sodium zirconium cyclosilicate
sodium zirconium cyclosilicate is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand name including LOKELMA. Available dosage form: powder, for suspension.
Drug Details
- Generic Name
- sodium zirconium cyclosilicate
- Brand Names
- LOKELMA
- Application Number
- NDA207078
- Sponsor
- AstraZeneca Pharmaceuticals LP
- NDC Codes
- 4
- Dosage Forms
- POWDER, FOR SUSPENSION
- Routes
- ORAL
- Active Ingredients
- SODIUM ZIRCONIUM CYCLOSILICATE
Indications and Usage
1 INDICATIONS AND USAGE LOKELMA is indicated for the treatment of hyperkalemia in adults. Limitation of Use LOKELMA should not be used as an emergency treatment for life-threatening hyperkalemia because of its delayed onset of action [see Clinical Pharmacology (12.2) and Clinical Studies (14) ] . LOKELMA is a potassium binder indicated for the treatment of hyperkalemia in adults. ( 1 ) Limitation of Use LOKELMA should not be used as an emergency treatment for life-threatening hyperkalemia because of its delayed onset of action. ( 1 )